Literature DB >> 9341587

The implantable cardioverter-defibrillator. A potential hazard for autopsy pathologists.

J A Prahlow1, J M Guileyardo, J J Barnard.   

Abstract

The implantable cardioverter-defibrillator (ICD) is an implantable electronic device that has been proven to be safe and effective in treating various malignant tachyarrhythmias in susceptible individuals. As the use of ICDs becomes more widespread, more individuals with the implanted devices will be encountered at autopsy. Manipulation of an activated ICD can result in electrical shock. To avoid injury, pathologists must be properly prepared to deal with bodies containing activated ICDs. These devices can also provide valuable information that may be helpful in determining the cause and mechanism of death. Herein, we present information regarding the appropriate guidelines and safeguards for pathologists confronted with an activated ICD.

Entities:  

Mesh:

Year:  1997        PMID: 9341587

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

Review 1.  Health and safety at necropsy.

Authors:  J L Burton
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

Review 2.  Acp. Best practice no 155. Pathological investigation of deaths following surgery, anaesthesia, and medical procedures.

Authors:  R D Start; S S Cross
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

3.  A prospective audit of pacemaker function, implant lifetime, and cause of death in the patient.

Authors:  S K Suvarna; R D Start; D I Tayler
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

4.  Cardiac conduction devices in the radiologic comparative identification of decedents.

Authors:  Vasiliki Chatzaraki; Garyfalia Ampanozi; Michael J Thali; Wolf Schweitzer
Journal:  Forensic Sci Med Pathol       Date:  2019-11-14       Impact factor: 2.007

5.  Making post-mortem implantable cardioverter defibrillator explantation safe.

Authors:  Sune B E W Räder; Volkert Zeijlemaker; Steen Pehrson; Jesper H Svendsen
Journal:  Europace       Date:  2009-10       Impact factor: 5.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.